
Cornucopian Capital is a venture capital firm based in Montclair, New Jersey, dedicated to advancing 'Medicine 3.0' — preventative, predictive, personalized, and participatory healthcare. The firm invests in companies enhancing healthspan, performance, and longevity across healthcare, biotech, consumer health, and food sectors, and also operates a venture studio/foundry model.
67% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-b (50% of deals). Average disclosed round size is $13.8M (across 6 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $19M | Jul 2026 | |
| Series B | $19M | Jul 2026 | |
| Series A | $12M | Jul 2025 | |
| Series A | $12M | Jun 2025 | |
| Series B | $15M | Sep 2022 | |
| Seed | $5.5M | — |
Top Co-Investors
NextView Ventures3 shared
nvp capital3 shared
Kleiner Perkins2 shared
Cobalt Capital2 shared
Angelini Ventures2 shared
OurCrowd1 shared
BASF Venture Capital1 shared
PeakBridge1 shared
AARP1 shared
HPA1 shared
25madison1 shared
Arkitekt Ventures1 shared
VamosVentures1 shared
Celtic House Asia Partners1 shared
City Light Capital1 shared
Last updated: 7 October 2026